Activated platelets in multiple sclerosis: Immunoinflammatory mechanisms and the therapeutic controversy of acetylsalicylic acid.
A narrative review explores how platelet activation may contribute to MS through blood-brain barrier dysfunction, immune-cell recruitment, oxidative stress, demyelination, and neurodegeneration, and critically examines acetylsalicylic acid (ASA) as a potential platelet-targeted strategy.